RAFFA WEALTH MANAGEMENT, LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.5K | Buy |
365
+30
| +9% | +$1.29K | ﹤0.01% | 313 |
|
|
2026
Q1 | $12.3K | Sell |
335
-32
| -9% | -$1.52K | ﹤0.01% | 346 |
|
|
2025
Q4 | $18.7K | Buy |
367
+30
| +9% | +$1.53K | ﹤0.01% | 274 |
|
|
2025
Q3 | $18.7K | Buy |
337
+40
| +13% | +$2.34K | ﹤0.01% | 269 |
|
|
2025
Q2 | $20.5K | Sell |
297
-56
| -16% | -$3.81K | ﹤0.01% | 272 |
|
|
2025
Q1 | $24.5K | Sell |
353
-55
| -13% | -$4.54K | 0.01% | 198 |
|
|
2024
Q4 | $35.1K | Buy |
408
+56
| +16% | +$6.06K | 0.01% | 175 |
|
|
2024
Q3 | $41.9K | Hold |
352
| – | – | 0.01% | 156 |
|
|
2024
Q2 | $50.2K | Hold |
352
| – | – | 0.01% | 195 |
|
|
2024
Q1 | $45.2K | Sell |
352
-13
| -4% | -$1.55K | 0.01% | 199 |
|
|
2023
Q4 | $37.8K | Sell |
365
-85
| -19% | -$8.41K | 0.01% | 147 |
|
|
2023
Q3 | $40.9K | Hold |
450
| – | – | 0.01% | 143 |
|
|
2023
Q2 | $36.4K | Hold |
450
| – | – | 0.01% | 153 |
|
|
2023
Q1 | $35.8K | Hold |
450
| – | – | 0.01% | 171 |
|
|
2022
Q4 | $30.5K | Sell |
450
-126
| -22% | -$7.39K | 0.01% | 172 |
|
|
2022
Q3 | $28.7K | Hold |
576
| – | – | 0.01% | 176 |
|
|
2022
Q2 | $32.1K | Hold |
576
| – | – | 0.01% | 170 |
|
|
2022
Q1 | $32K | Buy |
576
+32
| +6% | +$1.64K | 0.01% | 175 |
|
|
2021
Q4 | $30.5K | Hold |
544
| – | – | 0.01% | 186 |
|
|
2021
Q3 | $26.1K | Buy |
544
+120
| +28% | +$5.8K | 0.01% | 172 |
|
|
2021
Q2 | $17.8K | Sell |
424
-94
| -18% | -$3.64K | 0.01% | 205 |
|
|
2021
Q1 | $17.5K | Buy |
518
+38
| +8% | +$1.35K | 0.01% | 209 |
|
|
2020
Q4 | $16.8K | Buy |
480
+48
| +11% | +$1.66K | 0.01% | 199 |
|
|
2020
Q3 | $15K | Buy |
432
+54
| +14% | +$1.8K | 0.01% | 201 |
|
|
2020
Q2 | $12.4K | Buy |
378
+48
| +15% | +$1.53K | ﹤0.01% | 208 |
|
|
2020
Q1 | $9.93K | Buy |
+330
| New | +$9.83K | ﹤0.01% | 207 |
|
|
2017
Q1 | – | Sell |
-76
| Closed | -$1.36K | – | 702 |
|
|
2016
Q4 | $1.36K | Buy |
76
+26
| +52% | +$471 | ﹤0.01% | 353 |
|
|
2016
Q3 | $1.04K | Hold |
50
| – | – | ﹤0.01% | 399 |
|
|
2016
Q2 | $1.34K | Hold |
50
| – | – | ﹤0.01% | 331 |
|
|
2016
Q1 | $1.35K | Hold |
50
| – | – | ﹤0.01% | 323 |
|
|
2015
Q4 | $1.45K | Hold |
50
| – | – | ﹤0.01% | 310 |
|
|
2015
Q3 | $1.36K | Hold |
50
| – | – | ﹤0.01% | 325 |
|
|
2015
Q2 | $1.37K | Hold |
50
| – | – | ﹤0.01% | 324 |
|
|
2015
Q1 | $1.33K | Hold |
50
| – | – | ﹤0.01% | 322 |
|
|
2014
Q4 | $1.06K | Hold |
50
| – | – | ﹤0.01% | 348 |
|
|
2014
Q3 | $1.19K | Buy |
+50
| New | +$1.15K | ﹤0.01% | 312 |
|
|
2014
Q1 | – | Sell |
-250
| Closed | -$1.06K | – | 586 |
|
|
2013
Q4 | $1.06K | Buy |
+250
| New | +$4.36K | ﹤0.01% | 348 |
|
Other funds holding NVO
SRIM
SAM
GA
QI
AA
GIM
CFB
OFA
PM
RAFFA WEALTH MANAGEMENT, LLC's NVO Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its Novo Nordisk (NVO) stake by 9% in Q2 2026, buying an estimated $1.29K and bringing the position to 365 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #313.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in NVO in Q4 2013 and has held it in 37 quarters since. The position peaked at $50.2K in Q2 2024. 478 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 365 shares of Novo Nordisk worth $17.5K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 30 Novo Nordisk shares in Q2 2026, an estimated $1.29K.
- Novo Nordisk made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #313 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Novo Nordisk in Q4 2013 and has held it in 37 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Novo Nordisk position peaked at $50.2K in Q2 2024.
- 478 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.